Literature DB >> 20832765

Evidence-based management of herb-drug interaction in cancer chemotherapy.

Chung-Wah Cheng1, Wing Fan, Seong-Gyu Ko, Lisa Song, Zhao-Xiang Bian.   

Abstract

The fact that many cancer patients take herbal medicine, including Chinese herbal medicine, together with chemotherapy is well known. The potential for side effects resulting from concurrent use of these two different treatment modalities requires physicians to be aware of the potential risks and benefits that might arise. This study searched available evidence for herb-drug interaction in cancer therapy and identified 168 articles. Little direct evidence for such interaction could be found, whereas there is some indirect evidence for benefit. Hence, most of the concern about herb-drug interaction in chemotherapy appears to be theoretical. To resolve this discrepancy, evidence-based studies should be undertaken to document the positive and/or negative effects of the concomitant use of herbs with anticancer chemotherapeutic drugs. As evidence accumulates, it would be helpful to set up an internationally accessible database to document the use of Chinese medicine herbs with anticancer drugs. Once this information is collected, efforts should be made to educate health care professionals and patients about the use of Chinese herbal medicine together with Western drugs in treating cancer. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832765     DOI: 10.1016/j.explore.2010.06.004

Source DB:  PubMed          Journal:  Explore (NY)        ISSN: 1550-8307            Impact factor:   1.775


  15 in total

Review 1.  Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME.

Authors:  Zhen Yang; Kaustubh Kulkarni; Wei Zhu; Ming Hu
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

2.  Pristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage.

Authors:  Li Tong; Siddaraju M Nanjundaiah; Shivaprasad H Venkatesha; Brian Astry; Hua Yu; Kamal D Moudgil
Journal:  Clin Immunol       Date:  2014-10-13       Impact factor: 3.969

Review 3.  Gynura procumbens: An Overview of the Biological Activities.

Authors:  Hui-Li Tan; Kok-Gan Chan; Priyia Pusparajah; Learn-Han Lee; Bey-Hing Goh
Journal:  Front Pharmacol       Date:  2016-03-15       Impact factor: 5.810

4.  National survey of China's oncologists' knowledge, attitudes, and clinical practice patterns on complementary and alternative medicine.

Authors:  Geliang Yang; Richard Lee; Huiqing Zhang; Wei Gu; Peiying Yang; Changquan Ling
Journal:  Oncotarget       Date:  2017-02-21

5.  Momordica charantia Extract Induces Apoptosis in Human Cancer Cells through Caspase- and Mitochondria-Dependent Pathways.

Authors:  Chia-Jung Li; Shih-Fang Tsang; Chun-Hao Tsai; Hsin-Yi Tsai; Jong-Ho Chyuan; Hsue-Yin Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-04       Impact factor: 2.629

6.  Emerging glycolysis targeting and drug discovery from chinese medicine in cancer therapy.

Authors:  Zhiyu Wang; Neng Wang; Jianping Chen; Jiangang Shen
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-12       Impact factor: 2.629

Review 7.  Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries.

Authors:  Vidushi S Neergheen-Bhujun
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

8.  Prevalence of Polyherbacy in Ambulatory Visits to Traditional Chinese Medicine Clinics in Taiwan.

Authors:  Ming-Hwai Lin; Hsiao-Ting Chang; Chun-Yi Tu; Tzeng-Ji Chen; Shinn-Jang Hwang
Journal:  Int J Environ Res Public Health       Date:  2015-08-14       Impact factor: 3.390

9.  Impact of fixed-dose combination of germacrone, curdione, and furanodiene on breast cancer cell proliferation.

Authors:  Qi Kong; Fangyun Sun; Xiuping Chen
Journal:  Cell J       Date:  2013-07-02       Impact factor: 2.479

Review 10.  Understanding CAM Natural Health Products: Implications of Use Among Cancer Patients and Survivors.

Authors:  Judith M Fouladbakhsh; Lynda Balneaves; Elizabeth Jenuwine
Journal:  J Adv Pract Oncol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.